Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study

BackgroundThe outcomes of coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid (BP) remain insufficiently understood. This study aimed to evaluate the impact of COVID-19 on BP patients and identify factors influencing the risk and severity of severe acute respiratory syndrome coro...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yuexin Zhang, Dawei Huang, Yuling Shi, Yangfeng Ding, Yunlu Gao
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-04-01
Serija:	Frontiers in Immunology
Teme:	bullous pemphigoid COVID-19 SARS-CoV-2 glucocorticoids vaccination
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1568801/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!